Profiles

Profiles published here have completed one of the QIBA Profile Stages of development and been approved by their Biomarker Committee.

Profiles may be of use at any Stage.

Stage 3: Technically Confirmed Profiles

• CT Tumor Volume Change for Advanced Disease (CTV-AD) 2018-06-22

• FDG-PET/CT for Response to Cancer Therapy 2016-11-18

• UPICT Protocol - Oncology FDG-PET CT v2.0 Dec-2014

Stage 2: Consensus Profiles

• CT Small Lung Nodule Volume Assessment and Monitoring in Low Dose Screening 2018-11-18

• 18F-labeled PET tracers targeting Amyloid as an Imaging Biomarker 2018-06-20

• MR Elastography of the Liver 2018-05-02

• SPECT Quantifying Dopamine Transporters with 123 - Iodine Labeled Ioflupane in Neurodegenerative Disease v1.1 2017-06-26

• Checklist - SPECT Profile Conformance

• MR DCE Quantification v1.0 2012-08-08

Stage 1: Public Comment Profiles

Please submit comments using the online form

• QIBA CT Lung Density Profile_09.03.2019 (Contains Conformance Checklist, Appendix B) (Public Comment Open: August 19 - October 16, 2019)

• QIBA CT Lung Density Protocols-Appendix D, 2019-06-26 (Public Comment Open: August 19 - October 16, 2019)

• Diffusion-Weighted Magnetic Resonance Imaging Profile 2019-02-05 (closed on April 5th, 2019)

• Atherosclerosis Biomarkers by (C)CTA - 2019 Imaging Profile 2019-02-26 (closed on June 3rd, 2019)

Comment Resolutions are posted for Past Public Comments and Past Technical Confirmations .

Format for Citing Profiles

Cite QIBA Profile documents as:

Specific QIBA Biomarker Committee. Specific Profile Title, Quantitative Imaging Biomarkers Alliance. Version. Profile Stage. QIBA, Date. Available from: URL

Example:

QIBA SPECT Biomarker Committee. Quantifying Dopamine Transporters with 123Iodine Labeled Ioflupane in Neurodegenerative Diseases, Quantitative Imaging Biomarkers Alliance. Version 1.1. Profile Stage: Consensus. QIBA, June 30, 2017. Available from: http://qibawiki.rsna.org/index.php/Profiles

Statements of Endorsement

• Industry
• Clinical Sites
• Additional letters of support can be found here

See Also

• How to use QIBA Profiles
• Biomarker Committee pages may also have links to DRAFT Profile documents for the next Stage.
• Profile Conformance describes how sites and products claim conformance to a Profile.
• QIBA Profile Template shows the structure, rationale and content of a Profile (show "All Markup" to see guidance in the Word comments)

• Work Product for Review